Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ho-Jae Lee, Young-Min Han, Jeong Min An, Eun A. Kang, Yong Jin Park, Ji-Young Cha & Ki Baik Hahm. (2018) Role of omega-3 polyunsaturated fatty acids in preventing gastrointestinal cancers: current status and future perspectives. Expert Review of Anticancer Therapy 18:12, pages 1189-1203.
Read now
Read now
William G North, Fuli Liu, Liz Z Lin, Ruiyang Tian & Bonnie Akerman. (2017) NMDA receptors are important regulators of pancreatic cancer and are potential targets for treatment. Clinical Pharmacology: Advances and Applications 9, pages 79-86.
Read now
Read now
Pedro P López-Casas & Luís A López-Fernández. (2010) Gene-expression profiling in pancreatic cancer. Expert Review of Molecular Diagnostics 10:5, pages 591-601.
Read now
Read now
P. Correale, F. Montagnani, S. Miano, A. Sciandivasci, A. Pascucci, R. Petrioli, W. Testi, G. Tanzini & G. Francini. (2008) Biweekly Triple Combination Chemotherapy with Gemcitabine, Oxaliplatin, Levofolinic Acid and 5-Fluorouracil (GOLF) Is a Safe and Active Treatment for Patients with Inoperable Pancreatic Cancer. Journal of Chemotherapy 20:1, pages 119-125.
Read now
Read now
Ravi A Madan, Philip M Arlen & James L Gulley. (2007) PANVAC™-VF: poxviral-based vaccine therapy targeting CEA and MUC1 in carcinoma. Expert Opinion on Biological Therapy 7:4, pages 543-554.
Read now
Read now
Articles from other publishers (64)
Ebbin Joseph, Ian Smith & Jon A. Tunge. (2023) Cobalt-catalyzed decarboxylative difluoroalkylation of nitrophenylacetic acid salts. Chemical Science 14:47, pages 13902-13907.
Crossref
Crossref
Shukui Qin, Jin Li, Yuxian Bai, Zishu Wang, Zhendong Chen, Ruihua Xu, Jianming Xu, Hongmei Zhang, Jia Chen, Ying Yuan, Tianshu Liu, Lin Yang, Haijun Zhong, Donghui Chen, Lin Shen, Chunyi Hao, Deliang Fu, Ying Cheng, Jianwei Yang, Qiong Wang, Baoli Qin, Hongming Pan, Jun Zhang, Xianhong Bai & Qingshan Zheng. (2023) Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer. Journal of Clinical Oncology 41:33, pages 5163-5173.
Crossref
Crossref
Antara Sharma, Pranish Bomzan, Niloy Roy, Vikas Kumar Dakua, Kanak Roy, Abhinath Barman, Rabindra Dey, Abhijit Chhetri, Rajani Dewan, Ankita Dutta, Anoop Kumar & Mahendra Nath Roy. (2023) Exploring the Inclusion Complex of an Anticancer Drug with β-Cyclodextrin for Reducing Cytotoxicity Toward the Normal Human Cell Line by an Experimental and Computational Approach. ACS Omega 8:32, pages 29388-29400.
Crossref
Crossref
Liang Zhang, Kangjing Qi, Jie Xu, Yan Xing, Xuejian Wang, Ling Tong, Zengguo He, Wenfang Xu, Xiaoyang Li & Yuqi Jiang. (2023) Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine. Journal of Medicinal Chemistry 66:6, pages 4150-4166.
Crossref
Crossref
Xinlu Chai, Yuting Meng, Wei Ge, Juan Wang, Fei Li, Xue Jun Wang & Xuerong Wang. (2023) A novel synthesized prodrug of gemcitabine based on oxygen-free radical sensitivity inhibited the growth of lung cancer cells. The Journal of Biomedical Research 37:0, pages 1.
Crossref
Crossref
Ruquan WangYongliang LiJianjun GaoYepeng Luan. (2022) WRQ-2, a gemcitabine prodrug, reverses gemcitabine resistance caused by hENT1 inhibition. Drug Discoveries & Therapeutics 16:6, pages 286-292.
Crossref
Crossref
Zichen Xu, Bin Zhang, Zhixin Liao & Shaohua Gou. (2021) A gemcitabine-based conjugate with enhanced antitumor efficacy by suppressing HIF-1α expression under hypoxia. Bioorganic & Medicinal Chemistry 41, pages 116214.
Crossref
Crossref
Subhajit Makar, Abhrajyoti Ghosh, Divya, Shalini Shivhare, Ashok Kumar & Sushil K. Singh. (2021) Molecular Processes Involved in Pancreatic Cancer and Therapeutics. Current Chemical Biology 15:1, pages 85-108.
Crossref
Crossref
Jun Qu, Yeqi Zhou, Yuan Li, Jinsong Yu & Wei Wang. (2021) CASK regulates Notch pathway and functions as a tumor promoter in pancreatic cancer. Archives of Biochemistry and Biophysics 701, pages 108789.
Crossref
Crossref
He Miao, Xuehong Chen & Yepeng Luan. (2020) Small Molecular Gemcitabine Prodrugs for Cancer Therapy. Current Medicinal Chemistry 27:33, pages 5562-5582.
Crossref
Crossref
Roksana Trznadel, Aleksandra Singh, Natalia Kleczewska, Joanna Liberska, Piotr Ruszkowski & Lech Celewicz. (2019) Synthesis and in vitro anticancer activity of new gemcitabine-nucleoside analogue dimers containing methyltriazole or ester-methyltriazole linker. Bioorganic & Medicinal Chemistry Letters 29:18, pages 2587-2594.
Crossref
Crossref
Kun Shi, Bingxin Xue, Yanpeng Jia, Liping Yuan, Ruxia Han, Fan Yang, Jinrong Peng & Zhiyong Qian. (2019) Sustained co-delivery of gemcitabine and cis-platinum via biodegradable thermo-sensitive hydrogel for synergistic combination therapy of pancreatic cancer. Nano Research 12:6, pages 1389-1399.
Crossref
Crossref
Marcella Bassetto & Magdalena Slusarczyk. (2018) Therapeutic use of fluorinated nucleosides – progress in patents. Pharmaceutical Patent Analyst 7:6, pages 277-299.
Crossref
Crossref
Anthony J. Berdis. (2017) Inhibiting DNA Polymerases as a Therapeutic Intervention against Cancer. Frontiers in Molecular Biosciences 4.
Crossref
Crossref
Alessandra Cavaliere, Katrin C Probst, Andrew D Westwell & Magdalena Slusarczyk. (2017) Fluorinated nucleosides as an important class of anticancer and antiviral agents. Future Medicinal Chemistry 9:15, pages 1809-1833.
Crossref
Crossref
Jiali Ma, Pingping Hui, Wenying Meng, Na Wang & Shihao Xiang. (2017) Ku70 inhibits gemcitabine-induced DNA damage and pancreatic cancer cell apoptosis. Biochemical and Biophysical Research Communications 484:4, pages 746-752.
Crossref
Crossref
Hao Hu, Yuan He, Yandong Wang, Wuqiang Chen, Benshun Hu & YuanLong Gu. (2017) micorRNA-101 silences DNA-PKcs and sensitizes pancreatic cancer cells to gemcitabine. Biochemical and Biophysical Research Communications 483:1, pages 725-731.
Crossref
Crossref
Zhiming Wang, Hui Wu, Hongyuan Shi, Mingliang Wang, Chusen Huang & Nengqin Jia. (2016) A novel multifunctional biomimetic Au@BSA nanocarrier as a potential siRNA theranostic nanoplatform. Journal of Materials Chemistry B 4:14, pages 2519-2526.
Crossref
Crossref
Shang Minjie, Hong Defei, Hu Zhimin, Wu Weiding & Zhang Yuhua. (2015) Targeting pancreatic cancer cells by a novel hydroxamate-based histone deacetylase (HDAC) inhibitor ST-3595. Tumor Biology 36:11, pages 9015-9022.
Crossref
Crossref
Bo ChenMing XuHui ZhangMing-zheng XuXu-jing WangQing-he TangJian-ying Tang. (2015) The Antipancreatic Cancer Activity of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2. DNA and Cell Biology 34:10, pages 610-617.
Crossref
Crossref
Altaf Mohammed, Naveena Janakiram, Shubham Pant & Chinthalapally Rao. (2015) Molecular Targeted Intervention for Pancreatic Cancer. Cancers 7:3, pages 1499-1542.
Crossref
Crossref
María Labarca-Acosta, Eduardo Reyna-Villasmil, Jhoan Aragón-Charris & Joel Santos-Bolívar. (2015) Adenocarcinoma pancreático durante el embarazo. Cirugía Española 93:7, pages 479-481.
Crossref
Crossref
María Labarca-Acosta, Eduardo Reyna-Villasmil, Jhoan Aragón-Charris & Joel Santos-Bolívar. (2015) Pancreatic Adenocarcinoma During Pregnancy. Cirugía Española (English Edition) 93:7, pages 479-481.
Crossref
Crossref
Xiang-Lin Tan, Kalyan K. Bhattacharyya, Shamit K. Dutta, William R. Bamlet, Kari G. Rabe, Enfeng Wang, Thomas C. Smyrk, Ann L. Oberg, Gloria M. Petersen & Debabrata Mukhopadhyay. (2015) Metformin Suppresses Pancreatic Tumor Growth With Inhibition of NFκB/STAT3 Inflammatory Signaling. Pancreas 44:4, pages 636-647.
Crossref
Crossref
Michael Osterman, Deion Kathawa, Diangang Liu, Huan Guo, Chao Zhang, Mo Li, Xiaochun Yu & Fei Li. (2014) Elevated DNA damage response in pancreatic cancer. Histochemistry and Cell Biology 142:6, pages 713-720.
Crossref
Crossref
Martin Kerr, Helen E. Scott, Blaz Groselj, Michael R.L. Stratford, Katalin Karaszi, Naomi L. Sharma & Anne E. Kiltie. (2014) Deoxycytidine Kinase Expression Underpins Response to Gemcitabine in Bladder Cancer. Clinical Cancer Research 20:21, pages 5435-5445.
Crossref
Crossref
Magdalena Slusarczyk, Monica Huerta Lopez, Jan Balzarini, Malcolm Mason, Wen G. Jiang, Sarah Blagden, Emely Thompson, Essam Ghazaly & Christopher McGuigan. (2014) Application of ProTide Technology to Gemcitabine: A Successful Approach to Overcome the Key Cancer Resistance Mechanisms Leads to a New Agent (NUC-1031) in Clinical Development. Journal of Medicinal Chemistry 57:4, pages 1531-1542.
Crossref
Crossref
Kristen Larocque, Pamela Ovadje, Sinisa Djurdjevic, Mariam Mehdi, James Green & Siyaram Pandey. (2014) Novel Analogue of Colchicine Induces Selective Pro-Death Autophagy and Necrosis in Human Cancer Cells. PLoS ONE 9:1, pages e87064.
Crossref
Crossref
Jin-Gyun Lee, Kimberly Q. McKinney & Sun-Il Hwang. 2014. Molecular Diagnostics and Treatment of Pancreatic Cancer. Molecular Diagnostics and Treatment of Pancreatic Cancer
221
244
.
James R. McCarthy. 2013. Enzyme Technologies. Enzyme Technologies
237
251
.
Jin-Gyun Lee, Kimberly Q. McKinney, Jean-Luc Mougeot, Herbert L. Bonkovsky & Sun-Il Hwang. (2013) Proteomic strategy for probing complementary lethality of kinase inhibitors against pancreatic cancer. PROTEOMICS 13:23-24, pages 3554-3562.
Crossref
Crossref
Yasuhisa Mori, Takao Ohtsuka, Hiroshi Kono, Yosuke Nagayoshi, Noboru Ideno, Teppei Aso, Shingo Kozono, Kenoki Ohuchida, Shunichi Takahata, Masafumi Nakamura, Kazuhiro Mizumoto & Masao Tanaka. (2013) A Minimally Invasive and Simple Screening Test for Detection of Pancreatic Ductal Adenocarcinoma Using Biomarkers in Duodenal Juice. Pancreas 42:2, pages 187-192.
Crossref
Crossref
SUNG OK KIM & MI RYEO KIM. (2013) (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC-1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity. International Journal of Oncology 42:1, pages 349-358.
Crossref
Crossref
Balasubramanian Sivakumar, Ravindran Girija Aswathy, Yutaka Nagaoka, Seiki Iwai, Kizhikkilot Venugopal, Kazunori Kato, Yasuhiko Yoshida, Toru Maekawa & Dasappan Nair Sakthi Kumar. (2013) Aptamer conjugated theragnostic multifunctional magnetic nanoparticles as a nanoplatform for pancreatic cancer therapy. RSC Advances 3:43, pages 20579.
Crossref
Crossref
Altaf Mohammed, Naveena B. Janakiram, Misty Brewer, Ashley Duff, Stan Lightfoot, Richard S. Brush, Robert E. Anderson & Chinthalapally V. Rao. (2012) Endogenous n-3 Polyunsaturated Fatty Acids Delay Progression of Pancreatic Ductal Adenocarcinoma in Fat-1-p48Cre/+-LSL-KrasG12D/+ Mice. Neoplasia 14:12, pages 1249-IN46.
Crossref
Crossref
Altaf Mohammed, Li Qian, Naveena B. Janakiram, Stan Lightfoot, Vernon E. Steele & Chinthalapally V. Rao. (2012) Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice. International Journal of Cancer 131:8, pages 1951-1962.
Crossref
Crossref
Wenbo Zhu, Jingjie Li, Sihan Wu, Shifeng Li, Liang Le, Xingwen Su, Pengxin Qiu, Haiyan Hu & Guangmei Yan. (2012) Triptolide Cooperates With Cisplatin to Induce Apoptosis in Gemcitabine-Resistant Pancreatic Cancer. Pancreas 41:7, pages 1029-1038.
Crossref
Crossref
Chinthalapally V. Rao, Altaf Mohammed, Naveena B. Janakiram, Qian Li, Rebekah L. Ritchie, Stan Lightfoot, Awasthi Vibhudutta & Vernon E. Steele. (2012) Inhibition of Pancreatic Intraepithelial Neoplasia Progression to Carcinoma by Nitric Oxide-Releasing Aspirin in p48Cre/+-LSL-KrasG12D/+ Mice. Neoplasia 14:9, pages 778-IN1.
Crossref
Crossref
K Mross, C Dittrich, W E Aulitzky, D Strumberg, J Schutte, R M Schmid, S Hollerbach, M Merger, G Munzert, F Fleischer & M E Scheulen. (2012) A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas – a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network. British Journal of Cancer 107:2, pages 280-286.
Crossref
Crossref
Shin Hamada, Kennichi Satoh, Morihisa Hirota, Atsushi Kanno, Jun Umino, Hiromichi Ito, Atsushi Masamune, Kazuhiro Kikuta, Kiyoshi Kume & Tooru Shimosegawa. (2012) The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2. Journal of Cellular Physiology 227:2, pages 729-738.
Crossref
Crossref
Anthony J. Berdis. 2012. DNA Repair in Cancer Therapy. DNA Repair in Cancer Therapy
75
107
.
Satadal Chatterjee & Shobhan Gaddameedhi. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
48
.
Falko Lange, Katja Rateitschak, Brit Fitzner, Ralf Pöhland, Olaf Wolkenhauer & Robert Jaster. (2011) Studies on mechanisms of interferon-gamma action in pancreatic cancer using a data-driven and model-based approach. Molecular Cancer 10:1.
Crossref
Crossref
Tehsina Devji, Claire Reddy, Christina Woo, Suresh Awale, Shigetoshi Kadota & Dora Carrico-Moniz. (2011) Pancreatic anticancer activity of a novel geranylgeranylated coumarin derivative. Bioorganic & Medicinal Chemistry Letters 21:19, pages 5770-5773.
Crossref
Crossref
Masashi Kanai, Kenichi Yoshimura, Masanori Asada, Atsushi Imaizumi, Chihiro Suzuki, Shigemi Matsumoto, Takafumi Nishimura, Yukiko Mori, Toshihiko Masui, Yoshiya Kawaguchi, Kazuhiro Yanagihara, Shujiro Yazumi, Tsutomu Chiba, Sushovan Guha & Bharat B. Aggarwal. (2010) A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemotherapy and Pharmacology 68:1, pages 157-164.
Crossref
Crossref
Shin Hamada & Tooru Shimosegawa. (2011) Biomarkers of Pancreatic Cancer. Pancreatology 11:2, pages 14-19.
Crossref
Crossref
Altaf Mohammed, Naveena B. Janakiram, Qian Li, Venkateshwar Madka, Misty Ely, Stan Lightfoot, Howard Crawford, Vernon E. Steele & Chinthalapally V. Rao. (2010) The Epidermal Growth Factor Receptor Inhibitor Gefitinib Prevents the Progression of Pancreatic Lesions to Carcinoma in a Conditional LSL-KrasG12D/+ Transgenic Mouse Model. Cancer Prevention Research 3:11, pages 1417-1426.
Crossref
Crossref
Günter Schneider, Oliver H. Krämer, Petra Fritsche, Susanne Schüler, Roland M. Schmid & Dieter Saur. (2010) Targeting histone deacetylases in pancreatic ductal adenocarcinoma. Journal of Cellular and Molecular Medicine 14:6a, pages 1255-1263.
Crossref
Crossref
Dustin Deming, Peter Geiger, Herbert Chen, Muthusamy Kunnimalaiyaan & Kyle Holen. (2010) ZM336372 Induces Apoptosis Associated with Phosphorylation of GSK-3β in Pancreatic Adenocarcinoma Cell Lines. Journal of Surgical Research 161:1, pages 28-32.
Crossref
Crossref
Anthony P. Lam, Joseph A. Sparano, Vincent Vinciguerra, Allyson J. Ocean, Paul Christos, Howard Hochster, Fernando Camacho, Sanjay Goel, Sridhar Mani & Andreas Kaubisch. (2010) Phase II Study of Paclitaxel Plus the Protein Kinase C Inhibitor Bryostatin-1 in Advanced Pancreatic Carcinoma. American Journal of Clinical Oncology 33:2, pages 121-124.
Crossref
Crossref
Ji-Hui Du, Hou-De Zhang, Zhen-Jian Ma & Kun-Mei Ji. (2009) Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo. Cancer Chemotherapy and Pharmacology 65:5, pages 895-902.
Crossref
Crossref
David M. Bender, Jingqi Bao, Anne H. Dantzig, William D. Diseroad, Kevin L. Law, Nicholas A. Magnus, Jeffrey A. Peterson, Everett J. Perkins, Yangwei J. Pu, Susan M. Reutzel-Edens, David M. Remick, James J. Starling, Gregory A. Stephenson, Radhe K. Vaid, Deyi Zhang & James R. McCarthy. (2009) Synthesis, Crystallization, and Biological Evaluation of an Orally Active Prodrug of Gemcitabine. Journal of Medicinal Chemistry 52:22, pages 6958-6961.
Crossref
Crossref
P Ghaneh, E Costello & J P Neoptolemos. (2008) Biology and management of pancreatic cancer. Postgraduate Medical Journal 84:995, pages 478-497.
Crossref
Crossref
Yu-Ting Chang, Ming-Chu Chang, Shu-Chen Wei, Yu-Wen Tien, Chiun Hsu, Po-Chin Liang, Po-Nien Tsao, I-Shiow Jan & Jau-Min Wong. (2008) Serum Vascular Endothelial Growth Factor/Soluble Vascular Endothelial Growth Factor Receptor 1 Ratio Is an Independent Prognostic Marker in Pancreatic Cancer. Pancreas 37:2, pages 145-150.
Crossref
Crossref
James L. Gulley, Philip M. Arlen, Kwong-Yok Tsang, Junko Yokokawa, Claudia Palena, Diane J. Poole, Cinzia Remondo, Vittore Cereda, Jacquin L. Jones, Mary P. Pazdur, Jack P. Higgins, James W. Hodge, Seth M. Steinberg, Herbert Kotz, William L. Dahut & Jeffrey Schlom. (2008) Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma. Clinical Cancer Research 14:10, pages 3060-3069.
Crossref
Crossref
Alessandra Fabi, Alessandra Mirri, Alessandra Felici, Antonello Vidiri, Andrea Pace, Emanuele Occhipinti, Francesco Cognetti, Giorgio Arcangeli, Bruno Iandolo, Maria Antonia Carosi, Giulio Metro & Carmine Maria Carapella. (2007) Fixed dose-rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma: a dose-finding study. Journal of Neuro-Oncology 87:1, pages 79-84.
Crossref
Crossref
Christoph W. Michalski, Florian E. Oti, Mert Erkan, Danguole Sauliunaite, Frank Bergmann, Pal Pacher, Sandor Batkai, Michael W. Müller, Nathalia A. Giese, Helmut Friess & Jörg Kleeff. (2008) Cannabinoids in pancreatic cancer: Correlation with survival and pain. International Journal of Cancer 122:4, pages 742-750.
Crossref
Crossref
Naoto Ichihara, Yoshitsugu Kubota, Akira Kitanaka, Terukazu Tanaka & Tomohiko Taminato. (2008) Inhibition of Src reduces gemcitabine-induced cytotoxicity in human pancreatic cancer cell lines. Cancer Letters 260:1-2, pages 155-162.
Crossref
Crossref
Xuan-Fu Xu, Chuan-Gao Xie, Xing-Peng Wang, Jun Liu, Yong-Chun Yu, Hong-Lang Hu & Chuan-Yong Guo. (2008) Selective Inhibition of Cyclooxygenase-2 Suppresses the Growth of Pancreatic Cancer Cells in Vitro and in Vivo. The Tohoku Journal of Experimental Medicine 215:2, pages 149-157.
Crossref
Crossref
Don L. Gibbons, Robert A. Wolff & Gauri Varadhachary. 2008. Targeted Cancer Therapy. Targeted Cancer Therapy
271
287
.
Laleh G. Melstrom & Paul J. Grippo. 2008. Pancreatic Cancer. Pancreatic Cancer
137
158
.
Hitoshi Funahashi, Makoto Satake, David Dawson, Ngoc-An Huynh, Howard A. Reber, Oscar J. Hines & Guido Eibl. (2007) Delayed Progression of Pancreatic Intraepithelial Neoplasia in a Conditional KrasG12D Mouse Model by a Selective Cyclooxygenase-2 Inhibitor. Cancer Research 67:15, pages 7068-7071.
Crossref
Crossref
Nicholas J. Gaspar, Lingyun Li, Ann M. Kapoun, Satyanarayana Medicherla, Mamatha Reddy, Georgia Li, Gilbert O'Young, Diana Quon, Margaret Henson, Deborah L. Damm, Gladys T. Muiru, Alison Murphy, Linda S. Higgins, Sarvajit Chakravarty & Darren H. Wong. (2007) Inhibition of Transforming Growth Factor β Signaling Reduces Pancreatic Adenocarcinoma Growth and Invasiveness. Molecular Pharmacology 72:1, pages 152-161.
Crossref
Crossref
Susan Jones‐Bolin & Bruce Ruggeri. (2007) Orthotopic Model of Human Pancreatic Ductal Adenocarcinoma and Cancer Cachexia in Nude Mice. Current Protocols in Pharmacology 37:1.
Crossref
Crossref